SAN FRANCISCO--(BUSINESS WIRE)--Sep 28, 2025--

Innovaccer Inc., a leading healthcare AI company, today announced results from the VITAL-HF (Virtual Care to Improve Heart Failure Outcomes) randomized controlled trial, presented today at the Heart Failure Society of America (HFSA) Annual Scientific Meeting. The study showed that using Story Health by Innovaccer, a remote, digital care platform, clinicians were able to significantly improve the use of guideline-directed medical therapy for patients with heart failure with reduced ejection fraction (HFrEF) compared with usual care.

Conducted across seven U.S. health systems including Duke University Health System, Cleveland Clinic, and Ascension St. Vincent, VITAL-HF enrolled 178 adults with HFrEF who were not yet optimized on medical therap

See Full Page